Compound Detail
CHEMBL500576
TEMOPORFIN 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Oc1cccc(-c2c3nc(c(-c4cccc(O)c4)c4ccc([nH]4)c(-c4cccc(O)c4)c4nc(c(-c5cccc(O)c5)c5ccc2[nH]5)CC4)C=C3)c1
Basic Information
| ChEMBL ID | CHEMBL500576 |
| Name | TEMOPORFIN |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | LYPFDBRUNKHDGX-LWQDQPMZSA-N |
| Therapeutic | ✓ Yes |
13
Targets
25
Activities
2
Assay Types
0
PK Parameters
20
Publications
10
Known Names
9
Indications
1
Mechanisms
Molecular Properties
680.8
MW (Da)
9.76
ALogP
6
HBA
6
HBD
138.3
PSA (Ų)
0.11
QED
3
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2001 |
| Availability | Unknown |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Photosensitizer | - | - | ✓ | ✓ |
Indications
Carcinoma, Squamous Cell Carcinoma, Squamous Cell Head and Neck Neoplasms Head and Neck Neoplasms Neoplasms Bile Duct Neoplasms Nasopharyngeal Carcinoma Carcinoma Carcinoma, Non-Small-Cell Lung
ATC Classification
L01XD05
temoporfin
Level 1: ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
Level 2: ANTINEOPLASTIC AGENTS
Activity Summary
IC50 21 meas. best 8.12
EC50 4 meas. best 8.0
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| HCT-116 CHEMBL394 | IC50 | 8.12 | 7.8767 | 7.6 | 3 |
| West Nile virus CHEMBL613730 | EC50 | 8.0 | 8.0 | 10.0 | 1 |
| dengue virus type 2 CHEMBL613966 | EC50 | 7.7 | 7.7 | 20.0 | 1 |
| Zika virus CHEMBL4296612 | EC50 | 7.66 | 7.66 | 22.0 | 1 |
| Nonstructural protein 3 CHEMBL4523954 | EC50 | 7.66 | 7.66 | 22.0 | 1 |
| HL-60 CHEMBL383 | IC50 | 7.38 | 7.38 | 42.0 | 1 |
| 4T1 CHEMBL612589 | IC50 | 7.3 | 6.2167 | 50.0 | 3 |
| KYSE-150 cell line CHEMBL613998 | IC50 | 7.12 | 6.435 | 75.0 | 2 |
| ECa-109 cell line CHEMBL614668 | IC50 | 6.66 | 6.255 | 220.0 | 2 |
| Unchecked CHEMBL612545 | IC50 | 6.2 | 5.8567 | 630.0 | 3 |
| A549 CHEMBL392 | IC50 | 6.15 | 6.0733 | 702.0 | 3 |
| MDA-MB-231 CHEMBL400 | IC50 | 6.06 | 5.27 | 870.0 | 2 |
| Nonstructural protein 3 CHEMBL4523954 | IC50 | 5.96 | 5.96 | 1100.0 | 1 |
| HUVEC CHEMBL613979 | IC50 | 5.82 | 5.82 | 1500.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 19211252 | 10.1016/j.bmc.2009.01.035 | HCT-116 | 9 |
| 31945666 | 10.1016/j.ejmech.2020.112049 | ADMET | 8 |
| 31132530 | 10.1016/j.ejmech.2019.05.050 | A549 | 8 |
| 31945666 | 10.1016/j.ejmech.2020.112049 | Unchecked | 7 |
| 32916313 | 10.1016/j.ejmech.2020.112794 | Unchecked | 4 |
| 38354521 | 10.1016/j.ejmech.2024.116228 | KYSE-150 cell line | 4 |
| 31980339 | 10.1016/j.bmcl.2020.126965 | Nonstructural protein 3 | 3 |
| 31096157 | 10.1016/j.ejmech.2019.04.057 | Enterococcus faecalis | 3 |
| 32916313 | 10.1016/j.ejmech.2020.112794 | 4T1 | 2 |
| 16722648 | 10.1021/jm050997m | HCT-116 | 2 |
| 32916313 | 10.1016/j.ejmech.2020.112794 | MDA-MB-231 | 2 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 2 |
| 32916313 | 10.1016/j.ejmech.2020.112794 | HUVEC | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 38056302 | 10.1016/j.ejmech.2023.116012 | ECa-109 cell line | 2 |
| 33341498 | 10.1016/j.bmc.2020.115926 | HT-29 | 2 |
| 34458734 | 10.1039/D1MD00080B | West Nile virus | 2 |
| - | 10.21203/rs.3.rs-23951/v1 | SARS-CoV-2 | 1 |
| 38354521 | 10.1016/j.ejmech.2024.116228 | ADMET | 1 |
| - | 10.1039/C1MD00065A | No relevant target | 1 |
Data from ChEMBL 36 via Core Engine